621
Views & Citations10
Likes & Shares
Major depressive disorder (MDD) is a severe
psychiatric illness that is associated with significant morbidity and mortality.
About one in six individuals will succumb to clinical depression during their
lifetime. In addition to mortality associated with suicide, depressed patients
are more likely to develop dementia, coronary artery disease and type 2
diabetes. However, biological mechanisms underlying depression remains poorly
understood due to lack of biomarkers, relatively low rates of heritability, and
heterogeneity of precipitating factors, including stress. Despite advances in
the treatment of major depression, one-third of depressed patients fail to
respond to conventional antidepressant medication. One pathophysiologic
mechanism hypothesized to contribute to treatment resistance in depression is
neuroinflammation. Recent evidence has shown that MDD is also associated with
increased levels of inflammatory markers in the periphery. Recent work also
suggest that perfusion deficits in the elderly can trigger microglial
activation and subsequent neuroinflammation and shifts the CNS into a
proinflammatory state ultimately resulting in demyelination and
neurodegeneration. Of note, decreased inflammatory markers have also been
associated with remitted stages of depression in response to treatment with
conventional antidepressant medications.
Keywords: Aging;
Neuroinflammation; Depression; Mechanisms
DEPRESSION AND
INFLAMMATION
Major
depressive disorder (MDD) is a severe psychiatric illness that is associated
with significant morbidity and mortality. About one in six individuals will
succumb to clinical depression during their lifetime [1]. In addition to
mortality associated with suicide, depressed patients are more likely to
develop dementia, coronary artery disease and type 2 diabetes [2]. However,
biological mechanisms underlying depression remains poorly understood due to
lack of biomarkers, relatively low rates of heritability and heterogeneity of
precipitating factors, including stress [3]. Despite advances in the treatment
of major depression, one-third of depressed patients fail to respond to
conventional antidepressant medication [4].One pathophysiologic mechanism
hypothesized to contribute to treatment resistance in depression is
neuroinflammation. Recent evidence has shown that MDD is also associated with
increased levels of inflammatory markers in the periphery [5]. Of note,
decreased inflammatory markers have also been associated with remitted stages
of depression in response to treatment with conventional antidepressant
medications [6].
AGING, NEUROINFLAMMATION, SYNAPTIC PLASTICITY
AND DEPRESSIVE BEHAVIOR
Neuroinflammation
has been associated with greater rates of major depression. On a background of
systemic inflammation, proinflammatory cytokines can access the central nervous
system and interfere with serotonin metabolism, and reduce both synaptic
plasticity and hippocampal neurogenesis [7,8]. Evidence is accumulating showing
that reduced, enhanced and imbalanced neuroplasticity-synaptic plasticity,
neuronal remodeling and neurogenesis — is implicated in the etiology of neuropsychiatric
conditions including depression [9]. Recent studies suggest that microglia may
play a role in synaptic remodeling and plasticity in the healthy brain [10,11].
Furthermore, disrupting microglia-specific
CR3/C3 or CX3CR1 signaling resulted in sustained deficits in synaptic
connectivity [11]. Taken together these results highly suggest that there is a
deep connection between inflammation, microglia and neuroplasticity and mood
regulation.
AGING, PERFUSION
DEFICITS, INFLAMMATION AND DEPRESSION
Among elderly individuals, depressive
symptoms are common and burdensome [12]. In addition, another 15-25% of elders
experience depressive symptoms that, while not meeting criteria for major
depressive disorder, do cause significant distress and interfere with daily functioning
[13]. It is well known that normal aging is characterized by a chronic
low-grade, pro-inflammatory state [14], with an overexpression of systemic
inflammatory factors, including pro-inflammatory cytokines [15].
Previous studies in rodents indicate that
aging and preclinical neurodegenerative disease processes promote
proinflammatory states in older individuals and leads to the development of a
primed and immune-reactive population of microglia [16-19]. Recent data
suggests that the inflammatory process is potentially intricately linked with
multiple neurodegenerative pathways for depression and pro-inflammatory
cytokines [20] and plays a central role in the pathophysiology of both
depression and dementia [21-24]. Further, immune activation can be a
characteristic of depression [8,25] and precipitate depressive symptoms [26].
Recent work suggests that perfusion deficits
in the elderly can trigger microglial activation and subsequent
neuroinflammation and shifts the CNS into a proinflammatory state [19,27,28]
ultimately resulting in demyelination and neurodegeneration [29]. There is
strong evidence that in humans vascular disease vascular Abeta deposition in
the brain promotes development of depression and increases the risk of dementia
by causing loss of vascular autoregulation associated with rigidity of
arterioles, leading to infarction in the territory of their branching vessels
in the temporal cortex of patients with cerebral angiopathy (CAA). This is
associated with marked vascular/perivascular infiltration of inflammatory
cells, a condition mimicked in mice subjected to chronic cerebral hypo
perfusion [30,31].
Perfusion deficits do not need to cause
ischemia in order to influence brain function. Instead perfusion deficits may
thus contribute to the affective and cognitive symptoms observed in LLD.
Indeed, vascular dysregulation is common in LLD and CBF reductions can impair
regional brain function, contributing to affective and cognitive symptoms
[32,33]. The subcortical white matter is particularly susceptible to infarction
due to impaired autoregulation of the blood flow in terminal arterioles with
limited collateral flow. Depressed elders with white matter hyperintensities
(WMH) in the medial and lateral PFC, subcortical and temporal structures
exhibit reduced CBF in both white matter and gray matter regions [34].
1. de
Jonge P, Rosmalen JGM (2006) Comment on: Knol MJ, Twisk JWR, Beekman ATF, Heine
RJ, Snoek FJ, Pouwer F. (2006) depression as a risk factor for the onset of
type 2 diabetes mellitus. A meta-analysis. Diabetologia; 49: 837-845.
Diabetologia 49: 2797-2798.
2. Kessler
RC, Berglund P, Demler O, Jin R, Merikangas KR, et al. (2005) Lifetime
prevalence and age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593-602.
3. Krishnan
V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:
894-902.
4. Rush
AJ, Trivedi MH, Wisniewski SR, Nieenberg AA, Stewart JW, et al. (2006) Acute
and longer-term outcomes in depressed outpatients requiring one or several
treatment steps: A STAR*D report. Am J Psychiatry 163: 1905-1917.
5. Raison
CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, et al. (2013)A randomized
controlled trial of the tumor necrosis factor antagonist infliximab for
treatment-resistant depression: The role of baseline inflammatory biomarkers.
JAMA Psychiatry 70: 31-41.
6. Baune
BT, Smith E, Reppermund S, Air T, Samaras K, et al. (2012) Inflammatory
biomarkers predict depressive, but not anxiety symptoms during aging: The
prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37:
1521-1530.
7. Caraci
F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer’s disease:
Neurobiological links and common pharmacological targets. Eur J Pharmacol 626:
64-71.
8. Maes
M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, et al. (2009) The inflammatory
and neurodegenerative (I&ND) hypothesis of depression: Leads for future
research and new drug developments in depression. Metab Brain Dis 24: 27-53.
9. Pittenger
C (2013) Disorders of memory and plasticity in psychiatric disease. Dialog Clin
Neurosci 15: 455-463.
10. Paolicelli
RC, Bolasco G, Pagani F, Maggi L, Scianni M, et al. (2011) Synaptic pruning by
microglia is necessary for normal brain development. Science 333: 1456-1458.
11. Schafer
DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, et al. (2012) Microglia
sculpt postnatal neural circuits in an activity and complement-dependent
manner. Neuron 74: 691-705.
12. Luppa
M, Luck T, Ritschel F, Angermeyer MC, Villringer A, et al. (2013) Depression
and incident dementia. An 8 year population-based prospective study. PLoS One
8: e59246.
13. Brevik
EJ, Eikeland RA, Lundervold AJ (2013) Subthreshold depressive symptoms have a
negative impact on cognitive functioning in middle-aged and older males. Front
Psychol 4: 309.
14. Bruunsgaard
H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr
Opin Hematol 8: 131-136.
15. Capuron
L, Miller AH (2011) Immune system to brain signaling: Neuropsychopharmacological
implications. Pharmacol Ther 130: 226-238.
16. Henry
CJ, Huang Y, Wynne A M, Godbout JP (2008) Peripheral lipopolysaccharide (LPS)
challenge promotes microglial hyperactivity in aged mice that is associated
with exaggerated induction of both pro-inflammatory IL-1beta and
anti-inflammatory IL-10 cytokines. Brain Behav Immunity 23: 309-317.
17. Bilbo
SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior:
A critical role for the immune system. Front Behav Neurosci 3: 14.
18. Murray
C, Sanderson DJ, Barkus C, Deacon RMJ, Rawlins JNP, et al. (2012) Systemic
inflammation induces acute working memory deficits in the primed brain:
Relevance for delirium. Neurobiol Aging 33: 603-616.
19. Dilger
RN, Johnson RW (2008) Aging, microglial cell priming and the discordant central
inflammatory response to signals from the peripheral immune system. J Leukocyte
Biol 84: 932-939.
20. Walker
AK, Kavelaars A, Heijnen CJ, Dantzer R (2013) Neuroinflammation and comorbidity
of pain and depression. Pharmacol Rev 66: 80-101.
21. Maes
M (2011) Depression is an inflammatory disease, but cell-mediated immune
activation is the key component of depression. Progr Neuropsychopharmacol Biol
Psychiatry 35: 664-675.
22. Leonard
BE (2007) Inflammation, depression and dementia: Are they connected? Neurochem
Res 32: 1749-1756.
23. Rojo
LE, Fernández JA, Maccioni AA, Jimenez JM, Maccioni RB (2008)
Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of
Alzheimer's disease. Arch Med Res 39: 1-16.
24. Byers
AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol
7: 323-331.
25. Surtees
PG, Wainwright NWJ, Boekholdt SM, Luben RN, Wareham NJ, et al. (2008) Major
depression, C-reactive protein and incident ischemic heart disease in healthy
men and women. Psychosom Med 70: 850-855.
26. Taylor
WD, Aizenstein HJ, Alexopoulos GS (2013) The vascular depression hypothesis:
Mechanisms linking vascular disease with depression. Mol Psychiatry 18:
963-974.
27. Downes
CE, Crack PJ (2010) Neural injury following stroke: Are toll-like receptors the
link between the immune system and the CNS? Br J Pharmacol 160: 1872-1888.
28. Ransohoff
RM, Cardona AE (2010) The myeloid cells of the central nervous system
parenchyma. Nature 468: 253-262.
29. Becker
KG, Holmes KA, Zhang Y (2011) Aging-kb: A knowledge base for the study of the
aging process. Mechanisms of Ageing and Development 132: 592-594.
30. Reimer
MM, McQueen J, Searcy L, Scullion G, Zonta B, et al. (2011) Rapid disruption of
axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci 31:
18185-18194.
31. Okamoto
Y, Yamamoto T, Kalaria RN, Senzaki H, Maki T, et al. (2012) Cerebral
hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical
microinfarcts. Acta Neuropathologica 123: 381-394.
32. Paranthaman
R, Greenstein AS, Burns AS, Cruickshank JK, Heagerty AM, et al. (2010) Vascular
function in older adults with depressive disorder. Biol Psychiatry 68: 133-139.
33. Greenstein
AS, Paranthaman R, Burns A, Jackson A, Malik RA, et al. (2010) Cerebrovascular
damage in late-life depression is associated with structural and functional
abnormalities of subcutaneous small arteries. Hypertension 56: 734-740.
34. Brickman
AM, Zahra A, Muraskin J, Steffener J, Holland CM, et al. (2009) Reduction in
cerebral blood flow in areas appearing as white matter hyperintensities on
magnetic resonance imaging. Psychiatry Res 172: 117-120.
QUICK LINKS
- SUBMIT MANUSCRIPT
- RECOMMEND THE JOURNAL
-
SUBSCRIBE FOR ALERTS
RELATED JOURNALS
- Journal of Cancer Science and Treatment (ISSN:2641-7472)
- Journal of Oral Health and Dentistry (ISSN: 2638-499X)
- International Journal of Medical and Clinical Imaging (ISSN:2573-1084)
- Journal of Nursing and Occupational Health (ISSN: 2640-0845)
- Journal of Blood Transfusions and Diseases (ISSN:2641-4023)
- Journal of Psychiatry and Psychology Research (ISSN:2640-6136)
- Journal of Otolaryngology and Neurotology Research(ISSN:2641-6956)